This clinical trial evaluates the efficacy of adding abaloparatide to ongoing denosumab treatment in postmenopausal women with osteoporosis. The study aims to determine if this combination therapy can improve bone mineral density (BMD) compared to continued denosumab alone. The trial is sponsored by the Hospital for Special Surgery in New York, with collaboration from Radius Health, Inc.